A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota
A Pilot Study of Mindfulness-Based Stress Reduction (MBSR) in Patients With Cancer Experiencing Stress Who Live in Underserved and Rural Regions of Minnesota
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Clinical Trials Referral Office
- Phone Number: 855-776-0015
- Email: mayocliniccancerstudies@mayo.edu
Study Contact Backup
- Name: Ahauve Orusa, MD, MPH
- Phone Number: 507-284-5162
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Recruiting
- Mayo Clinic in Rochester
-
Principal Investigator:
- Stacy D. D'Andre
-
Contact:
- Clinical Trials Referral Office
- Phone Number: 855-776-0015
- Email: mayocliniccancerstudies@mayo.edu
-
Contact:
- Ahauve Oruse, MD, MPH
- Phone Number: 507-284-5162
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with a history of cancer, or currently have cancer
- Patients reporting > 4/10 emotional distress on a 0-10 scale within the past six months
- Patients with a Rural-Urban Commuting Area (RUCA) code of 4 or greater
- Have a computer or smartphone
- Willing to complete questionnaires
Exclusion Criteria:
- Non-English-speaking patients
- Life expectancy < 12 months
- Active psychiatric disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Supportive care (MBSR)
Patients participate in MBSR sessions weekly for 8 weeks.
|
Ancillary studies
Ancillary studies
Receive MBSR intervention
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completion Rate
Time Frame: Up to 10 weeks
|
Assessed by the number of participants who complete the virtual stress reduction program (MBSR) program
|
Up to 10 weeks
|
|
Change in Stress
Time Frame: Baseline, at course completion (week 10), 3 months, 6 months
|
Assessed using the 10-item Perceived Stress Scale (PSS), which measures global perceived stress experienced by the participant over the preceding 30 days.
The PSS consists of 10 questions assessing how often the participant felt or thought a certain way during the past month.
Possible answers include: 0 - never; 1 - almost never; 2 - sometimes; 3 - fairly often, and 4 - very often.
Possible scores range from 0 to 40, with lower scores indicating a better outcome (less stress).
|
Baseline, at course completion (week 10), 3 months, 6 months
|
|
Change in Anxiety
Time Frame: Baseline, at course completion (week 10), 3 months, 6 months
|
Assessed using the General Anxiety Disorder 7-item (GAD-7) scale.
The GAD-7 consists of 7 questions answered on a scale of 0-3 where 0=not at all, 1=several days, 2=more than half the days, and 3=nearly every days.
The total score ranges from 0 to 21 where 0 indicates no anxiety, 1-4 indicates minimal anxiety, 5-9 indicates mild anxiety, 10-14 indicates moderate anxiety, and 15-21 indicates severe anxiety.
|
Baseline, at course completion (week 10), 3 months, 6 months
|
|
Change in Mindfulness
Time Frame: Baseline, at course completion (week 10), 3 months, 6 months
|
Assessed using the Mindful Attention Awareness Scale (MAAS), a 15-item scale designed to assess a core characteristic of dispositional mindfulness (open or receptive awareness of and attention to what is taking place in the present).
The MAAS consists of 15 statements about everyday experience, with each item answered on a scale ranging from 1 (almost always) to 6 (almost never) to indicate how frequently or infrequently participants have each experience.
The MAAS is scored by computing a mean (average) of all 15 items.
Higher scores reflect higher levels of dispositional mindfulness.
|
Baseline, at course completion (week 10), 3 months, 6 months
|
|
Barriers to completion of the course
Time Frame: At course completion (week 10)
|
Assessed using a study-specific questionnaire.
Responses will be evaluated and reported descriptively.
|
At course completion (week 10)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Stacy D. D'Andre, MD, Mayo Clinic in Rochester
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 24-013451 (Mayo Clinic Institutional Review Board)
- NCI-2025-08924 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.